PACS Group, Inc. (PACS)
(Real Time Quote from BATS)
$41.72 USD
+0.40 (0.97%)
Updated Aug 26, 2024 12:20 PM ET
3-Hold of 5 3
B Value C Growth F Momentum D VGM
PACS Group, Inc. (PACS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$38.14 | $44.00 | $32.00 | -7.70% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for PACS Group, Inc. comes to $38.14. The forecasts range from a low of $32.00 to a high of $44.00. The average price target represents a decline of 7.7% from the last closing price of $41.32.
Analyst Price Targets (7 )
Broker Rating
PACS Group, Inc. currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 85.71% and 14.29% of all recommendations. A month ago, Strong Buy made up 85.71%, while Buy represented 14.29%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/PACS.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.14 | 1.14 | 1.14 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
8/13/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/13/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/13/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
6/28/2024 | Macquarie Capital Securities | Tao Qiu | Not Available | Strong Buy |
5/6/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.14 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 7 |
Average Target Price | $38.14 |
LT Growth Rate | 15.00% |
Industry | Medical Services |
Industry Rank by ABR | 148 of 253 |
Current Quarter EPS Est: | 0.33 |